Hiroshi Matsumoto

This inventor holds 7 USPTO granted patents. Top assignees: Taiho Pharmaceutical Company Limited, Synphar Laboratories, Inc.. Active years: 1989-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Matsumoto. Retrieved from https://idiyas.com/inventor/hiroshi-matsumoto-jpi16opt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Tokushima-ken, JP (1996)
Iokushima, JP (1996)
Tokushima, JP (1989 - 1999)

Company Filing History:

7 out of 320

Taiho Pharmaceutical Company Limited

patents

3 out of 21

Synphar Laboratories, Inc.

patents

where one patent can have more than one assignee

Years Active: 1989-1999

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5994342 - 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives (1999-11-30),

2. 5698528 - Substance IT-62-B and medicinal composition containing the same (1997-12-16),

3. 5652234 - 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as (1997-07-29),

4. 5585373 - 3-(7'-oxo-1'-aza-4'-oxabicyclo[3.2.0]-hept-3'-YL)propionic acid (1996-12-17),

5. 5561126 - 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents (1996-10-01),

6. 5250673 - 2'-deoxy-5-substituted uridine derivatives (1993-10-05),

7. 4886877 - Novel 2'-deoxy-5-substituted uridine derivatives, processes for (1989-12-12),

Title: The Innovative Contributions of Hiroshi Matsumoto

Introduction

Hiroshi Matsumoto is a noteworthy inventor hailing from Tokushima, Japan. With an impressive portfolio of seven patents, Matsumoto has made significant strides in the field of medicinal chemistry. His work is characterized by a commitment to developing innovative compounds that have the potential to impact healthcare positively.

Latest Patents

Matsumoto’s recent inventions include the patent for 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives, known as Substance IT-62-B, along with a medicinal composition containing the same. These patents demonstrate his focus on creating new therapeutic options aimed at various medical conditions, showcasing his dedication to advancing pharmaceutical science.

Career Highlights

Throughout his career, Hiroshi Matsumoto has been associated with several prestigious organizations, including Taiho Pharmaceutical Company Limited and Synphar Laboratories, Inc. His tenure in these companies reflects his valuable contributions to the development of innovative drug formulations and delivery systems.

Collaborations

Matsumoto has worked alongside talented professionals in the field, including his coworkers Tomohiro Yamashita and Toshio Otani. Their collaborative efforts have played a significant role in the advancement of their projects, fostering an environment of shared knowledge and innovation.

Conclusion

In summary, Hiroshi Matsumoto is a distinguished inventor whose work continues to influence the pharmaceutical industry. With his latest patents highlighting groundbreaking medicinal compounds and his experience in reputable companies, Matsumoto's legacy is sure to inspire future innovators in the realm of medical science. His dedication to invention reflects the ongoing pursuit of advancements that can improve life quality and healthcare outcomes.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]